- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: BG00010 (Neublastin)
Total 115 results
-
BiogenElan PharmaceuticalsCompleted
-
BiogenCompletedMultiple Sclerosis, Relapsing-RemittingUnited States, Spain, Canada, Australia, Germany, Italy, United Kingdom, Belgium, Netherlands, France, Israel
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisUnited States
-
BiogenCompletedFatigue | Relapsing-Remitting Multiple SclerosisSweden, Norway, Austria, Denmark
-
BiogenCompleted
-
BiogenTerminatedRelapsing Multiple SclerosisBelgium
-
BiogenTerminatedCrohn's DiseaseUnited States, Puerto Rico
-
BiogenTerminatedMultiple Sclerosis, Secondary ProgressiveUnited States, Poland, Belgium, Slovakia, Czech Republic, Netherlands
-
BiogenActive, not recruiting
-
BiogenCompletedRelapsing Remitting Multiple SclerosisPortugal
-
BiogenTerminatedRelapsing Multiple SclerosisUnited States
-
BiogenCompletedAcute Ischemic StrokeSpain, United States, Germany
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple SclerosisJapan
-
BiogenCompletedMultiple Sclerosis | Exposure During PregnancySpain, Italy, Australia, Poland, United Kingdom, United States, Canada, France, Germany, Ireland
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisItaly
-
BiogenCompleted
-
BiogenCompleted
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisRussian Federation
-
BiogenCompletedRelapsing-Remitting Multiple Sclerosis
-
BiogenElan PharmaceuticalsCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
BiogenElan Pharmaceuticals; United BioSource, LLCCompleted
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple SclerosisUnited States
-
BiogenCompletedRelapsing Forms of Multiple SclerosisUnited States
-
BiogenTerminatedMultiple Sclerosis, Relapsing-Remitting | Relapsing-Remitting Multiple SclerosisCanada
-
BiogenCompleted
-
BiogenElan PharmaceuticalsCompleted
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisUnited States, France, Germany, Spain, Belgium, Czechia, Switzerland, United Kingdom, Austria, New Zealand, Australia, South Africa, Ukraine, Italy, Slovakia, Greece, Poland, Israel, Netherlands, Bulgaria, Serbia, India, Romania, Estonia and more
-
BiogenElan PharmaceuticalsCompletedMultiple SclerosisUnited States
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisUnited States, Croatia, Bulgaria, Czech Republic, France, Mexico, Poland, Spain, Germany, Belarus, Estonia, Latvia, Romania, Ukraine, Israel, New Zealand, Slovakia, Greece, India, Serbia, Ireland, Costa Rica, Canada, Belgium, Macedonia,... and more
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisFrance, Italy, Spain, Germany, Belgium
-
BiogenNot yet recruiting
-
BiogenCompletedProgressive Multifocal LeukoencephalopathyUnited States
-
Yale UniversityNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)CompletedHypophosphatemic Rickets, X Linked DominantUnited States
-
BiogenTerminated
-
BiogenActive, not recruitingRelapsing-Remitting Multiple SclerosisItaly, Belgium, United States, Hungary, Sweden, United Kingdom, Israel, France, Czechia, Poland, Serbia, Denmark, Spain, Turkey, Bulgaria, Germany, Canada, Kuwait
-
BiogenCompleted
-
BiogenTerminatedRelapsing-Remitting Multiple SclerosisUnited States, Spain, Germany, Australia, Sweden, Czechia, France, Italy, United Kingdom
-
BiogenCompleted
-
BiogenCompleted
-
BiogenCompletedRelapsing Forms of Multiple SclerosisUnited States
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisUnited Kingdom, Ireland
-
BiogenElan PharmaceuticalsTerminatedRelapsing Remitting Multiple SclerosisUnited States, Czech Republic, Italy, Spain, Sweden, Latvia, Finland, Hungary, Poland, Slovenia, Australia, Canada, France
-
National Cancer Institute (NCI)CompletedTivantinib and Topotecan Hydrochloride in Treating Patients With Advanced or Metastatic Solid TumorsAdult Solid NeoplasmUnited States
-
BiogenRecruitingMultiple SclerosisUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Uterine Corpus Sarcoma | Uterine Corpus LeiomyosarcomaUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)TerminatedUterine Corpus Leiomyosarcoma | Stage I Uterine Sarcoma AJCC v7United States, Belgium, France, Spain, United Kingdom, Netherlands, Norway, Venezuela
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingPreviously Treated Myelodysplastic Syndrome | Myelodysplastic Syndrome | Aplastic Anemia | de Novo Myelodysplastic SyndromeUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | High Risk Myelodysplastic SyndromeUnited States